Alison Calver

5.6k total citations · 1 hit paper
39 papers, 4.4k citations indexed

About

Alison Calver is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Alison Calver has authored 39 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 14 papers in Physiology and 11 papers in Surgery. Recurrent topics in Alison Calver's work include Nitric Oxide and Endothelin Effects (14 papers), Coronary Interventions and Diagnostics (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alison Calver is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Coronary Interventions and Diagnostics (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alison Calver collaborates with scholars based in United Kingdom and United States. Alison Calver's co-authors include Joe Collier, Patrick Vallance, A. Leone, Salvador Moncada, Patrick Vallance, Anna Leone, Brian F. Robinson, David J. Webb, Nigel Benjamin and Nick Curzen and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Hypertension.

In The Last Decade

Alison Calver

37 papers receiving 4.2k citations

Hit Papers

Accumulation of an endogenous inhibitor of nitric oxide s... 1992 2026 2003 2014 1992 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Calver United Kingdom 19 2.5k 2.5k 643 578 432 39 4.4k
Yasuaki Dohi Japan 33 1.7k 0.7× 2.4k 1.0× 426 0.7× 483 0.8× 603 1.4× 150 4.2k
Johan Van de Voorde Belgium 27 1.8k 0.7× 1.1k 0.5× 591 0.9× 425 0.7× 498 1.2× 121 4.1k
Karsten Sydow Germany 29 2.0k 0.8× 1.7k 0.7× 568 0.9× 681 1.2× 266 0.6× 53 4.3k
Sidney Shaw Switzerland 40 2.0k 0.8× 2.7k 1.1× 282 0.4× 756 1.3× 998 2.3× 109 5.1k
David J. Webb United Kingdom 33 2.5k 1.0× 2.2k 0.9× 230 0.4× 503 0.9× 422 1.0× 81 4.3k
Thomas F. Lüscher Switzerland 30 1.9k 0.8× 2.2k 0.9× 446 0.7× 554 1.0× 634 1.5× 65 3.8k
Friedrich Schulze Germany 22 1.2k 0.5× 1.3k 0.5× 274 0.4× 574 1.0× 420 1.0× 39 2.9k
Koji Fujii Japan 30 1.4k 0.5× 1.1k 0.4× 518 0.8× 819 1.4× 543 1.3× 109 3.4k
Aaron Hoffman Israel 32 1.0k 0.4× 1.2k 0.5× 333 0.5× 1.1k 1.9× 457 1.1× 109 4.4k
Luis A. Juncos United States 35 1.0k 0.4× 919 0.4× 311 0.5× 495 0.9× 511 1.2× 124 3.5k

Countries citing papers authored by Alison Calver

Since Specialization
Citations

This map shows the geographic impact of Alison Calver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Calver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Calver more than expected).

Fields of papers citing papers by Alison Calver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Calver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Calver. The network helps show where Alison Calver may publish in the future.

Co-authorship network of co-authors of Alison Calver

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Calver. A scholar is included among the top collaborators of Alison Calver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Calver. Alison Calver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hinton, Jonathan, Zoe Nicholas, Chun Shing Kwok, et al.. (2023). Association between troponin level and medium-term mortality in 20 000 hospital patients. Heart. 109(23). 1772–1777. 6 indexed citations
2.
Chapman, Andrew R., Thomas Gilpin, Mark A. Westwood, et al.. (2022). The effect of COVID-19 on training in cardiology: a survey of UK cardiology trainees. European Heart Journal. 43(Supplement_2). 1 indexed citations
3.
Hinton, Jonathan, Zoe Nicholas, Chun Shing Kwok, et al.. (2021). Relation of High-Sensitivity Troponin to 1 Year Mortality in 20,000 Consecutive Hospital Patients Undergoing a Blood Test for Any Reason. The American Journal of Cardiology. 158. 124–131. 1 indexed citations
4.
Hinton, Jonathan, Zoe Nicholas, Alison Calver, et al.. (2019). True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study. BMJ. 364. l729–l729. 39 indexed citations
5.
Joshi, Abhishek, Christopher Allen, Jubin Joseph, et al.. (2019). Women in Cardiology. European Heart Journal. 40(3). 227–231. 18 indexed citations
6.
7.
Sambu, Nalyaka, Borislav D. Dimitrov, Nicola A. Englyst, et al.. (2015). Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?. Journal of Thrombosis and Haemostasis. 13(6). 920–930. 8 indexed citations
8.
Curzen, Nick, Omer Rana, Zoe Nicholas, et al.. (2014). Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?. Circulation Cardiovascular Interventions. 7(2). 248–255. 151 indexed citations
9.
Sambu, Nalyaka, Alison Calver, Simon Corbett, et al.. (2012). Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry. Heart. 98(9). 706–711. 53 indexed citations
11.
Curzen, Nick, Geraint Morton, Alex Hobson, et al.. (2007). Stent thrombosis and antiplatelet therapy: a review of 3004 consecutive patients in a single centre. ePrints Soton (University of Southampton). 2 indexed citations
12.
Boos, Christopher J., et al.. (2005). Uterine artery embolisation for massive uterine fibroids in the presence of submassive pulmonary emboli. BJOG An International Journal of Obstetrics & Gynaecology. 112(10). 1440–1442. 4 indexed citations
13.
Calver, Alison, Keith D. Dawkins, & Anthony P. Salmon. (2000). Combined Percutaneous Management of an Atrial Septal Defect and Coronary Artery Disease. Journal of Interventional Cardiology. 13(1). 35–37. 2 indexed citations
14.
Calver, Alison, et al.. (2000). Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents. American Heart Journal. 140(3). 483–491. 32 indexed citations
15.
MacAllister, RJ, Alison Calver, Jan Riezebos, Joe Collier, & Patrick Vallance. (1995). Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 154–160. 51 indexed citations
16.
Calver, Alison, Joe Collier, & Patrick Vallance. (1994). Role of nitric oxide in cardiovascular control in healthy subjects and in patients with renal failure.. PubMed. 23. 223–32. 1 indexed citations
17.
Calver, Alison, Joe Collier, & Patrick Vallance. (1993). Nitric oxide and cardiovascular control. Experimental Physiology. 78(3). 303–326. 139 indexed citations
18.
Leone, A., et al.. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. The Lancet. 339(8793). 572–575. 1759 indexed citations breakdown →
19.
Vallance, Patrick, Anna Leone, Alison Calver, Joe Collier, & Salvador Moncada. (1992). Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis. Journal of Cardiovascular Pharmacology. 20. S60–S62. 388 indexed citations
20.
Calver, Alison, Joe Collier, & Patrick Vallance. (1992). Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.. Journal of Clinical Investigation. 90(6). 2548–2554. 445 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026